YANG Yong-Yu,HU Chang-Ping.Obesity and adipose tissue remodeling[J].Chinese Pharmacological Bulletin,2016,(01):9-13.[doi:10.3969/j.issn.1001-1978.2016.01.003]





Obesity and adipose tissue remodeling
1.中南大学药学院药理学系,湖南 长沙 410078; 2.中南大学湘雅二医院药学部,湖南 长沙 410011
YANG Yong-Yu12 HU Chang-Ping1
1.Dept of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha 410078, China; 2.Dept of Pharmacy, Second Xiangya Hospital, Central South University, Changsha 410011, China
肥胖 脂肪组织重构 细胞外基质 血管新生 炎症 代谢健康型肥胖
obesity adipose tissue remodeling extracellular matrix angiogenesis inflammation metabolically healthy obese
R-05; R329.52; R364.3; R364.5; R589.2
Obesity is a major risk factor for the generation and development of diabetes, atherosclerosis, hyperlipidemia and cancer. Obesity is accompanied with remodeling of adipose tissue, such as changed cell component and function, angiogenesis, extracellular matrix remodeling and infiltration of inflammatory cells. It is important for the prevention of obesity to study adipose tissue remodeling. This review summarizes recent advances in adipose tissue remodeling.


[1] Hansen J C, Gilman A P, Odland J O. Is thermogenesis a significant causal factor in preventing the “globesity” epidemic[J]. Med Hypotheses, 2010, 75(2): 250-6.
[2] Itoh M, Suganami T, Hachiya R, Ogawa Y. Adipose tissue remodeling as homeostatic inflammation[J]. Int J Inflam, 2011, 2011: 720926.
[3] Yin H, Pasut A, Soleimani V D, et al. MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16[J]. Cell Met,2013,17(2): 210-24.
[4] Sepe A, Tchkonia T, Thomou T, et al. Aging and regional differences in fat cell progenitors-a mini-review[J]. Gerontology, 2011, 57(1): 66-75.
[5] Sorisky A, Molgat A S, Gagnon A. Macrophage-induced adipose tissue dysfunction and the preadipocyte: should I stay(and differentiate)or should I go[J]. Adv Nutr, 2013, 4(1): 67-75.
[6] Morgan-Bathke M, Chen L, Oberschneider E, et al. Sex and depot differences in ex vivo adipose tissue fatty acid storage and glycerol-3-phosphate acyltransferase activity[J]. Am J Physiol Endocrinol Met,2015, 308(9): E830-46.
[7] Onate B, Vilahur G, Ferrer-Lorente R,et al. The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patients[J]. FASEB J, 2012, 26(10): 4327-36.
[8] Suganami T, Ogawa Y. Role of chronic inflammation in adipose tissue in the pathophysiology of obesity[J]. Nihon Rinsho, 2013, 71(2): 225-30.
[9] Khan T, Muise E S, Iyengar P, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI[J]. Mol Cell Biol, 2009, 29(6): 1575-91.
[10] Geys L, Scroyen I, Roose E, et al. ADAMTS13 deficiency in mice does not affect adipose tissue development[J]. Biochim Biophys Acta, 2015, 1850(7): 1368-74.
[11] Mariman E C, Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity[J]. Cell Mol Life Sci, 2010, 67(8): 1277-92.
[12] Chun T H, Inoue M, Morisaki H, et al. Genetic link between obesity and MMP14-dependent adipogenic collagen turnover[J]. Diabetes, 2010, 59(10): 2484-94.
[13] Shih C L, Ajuwon K M. Inhibition of MMP-13 prevents diet-induced obesity in mice and suppresses adipogenesis in 3T3-L1 preadipocytes[J]. Mol Biol Rep, 2015, 42(7): 1225-32.
[14] Bauters D, Scroyen I, Van Hul M, Lijnen H R. Gelatinase A(MMP-2)promotes murine adipogenesis[J]. Biochim Biophys Acta, 2015, 1850(7): 1449-56.
[15] Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases[J]. Nat Rev Drug Discov, 2010, 9(2): 107-15.
[16] Martinez-Santibanez G, Lumeng C N. Macrophages and the regulation of adipose tissue remodeling[J]. Annu Rev Nutr, 2014, 34: 57-76.
[17] Tam J, Duda D G, Perentes J Y, et al. Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells[J]. PLoS One, 2009, 4(3): e4974.
[18] Sun K, Wernstedt A I, Kusminski C M, et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction[J]. Proc Natl Acad Sci USA, 2012, 109(15): 5874-9.
[19] Lee M J, Wu Y, Fried S K. Adipose tissue remodeling in pathophysiology of obesity[J]. Curr Opin Clin Nutr Metab Care, 2010, 13(4): 371-6.
[20] Xue Y, Petrovic N, Cao R, et al. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation[J]. Cell Met,2009, 9(1): 99-109.
[21] Gu P, Xu A. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction[J]. Rev Endocr Metab Disord, 2013, 14(1): 49-58.
[22] Alligier M, Meugnier E, Debard C, et al. Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans[J]. J Clin Endocrinol Metab, 2012, 97(2): E183-92.
[23] Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice[J]. Am J Physiol Endocrinol Metab, 2007, 293(4): E1118-28.
[24] Goossens G H, Blaak E E. Adipose tissue oxygen tension: implications for chronic metabolic and inflammatory diseases[J]. Curr Opin Clin Nutr Metab Care, 2012, 15(6): 539-46.
[25] Harford K A, Reynolds C M, Mcgillicuddy F C, Roche H M. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue[J]. Proc Nutr Soc, 2011, 70(4): 408-17.
[26] Suganami T, Tanaka M, Ogawa Y. Adipose tissue inflammation and ectopic lipid accumulation[J]. Endocr J, 2012, 59(10): 849-57.
[27] Elgazar-Carmon V, Rudich A, Hadad N, Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding[J]. J Lipid Res, 2008, 49(9): 1894-903.
[28] Liu J, Divoux A, Sun J,et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice[J]. Nat Med, 2009, 15(8): 940-5.
[29] Sun K, Kusminski C M, Scherer P E. Adipose tissue remodeling and obesity[J]. J Clin Invest, 2011, 121(6): 2094-101.
[30] Kloting N, Fasshauer M, Dietrich A,et al. Insulink-sensitive obesity[J]. Am J Physiol Endocrinol Metab, 2010, 299(3): E506-15.


 CHEN Zhou,LIAO Li ping,LIU Li bin.The effect of sibutramine hydrochloride on expression of hypothalamus orexin system gene in highfat dietary obesity rats[J].Chinese Pharmacological Bulletin,2008,(01):0.
 CUI Ming xia,GAO Bei,MIN Guang ning,et al.Effect of duration of preparation on the formation of DIO model in rats[J].Chinese Pharmacological Bulletin,2008,(01):0.
 L Qi huan,WANG You min,DING Xiao jie,et al.Effect of pioglitazone on visfatin expression in highfat diets fed SD rats[J].Chinese Pharmacological Bulletin,2009,(01):0.
 NIE Xu qiang,YU Lin hua,CHEN Huai hong,et al.Intervention effects of rutaecarpine in type 2 diabetic obese rats[J].Chinese Pharmacological Bulletin,2010,(01):872.
[5]朱勇,汪长东,刘革力,等. 鸭MCHR2的基因克隆及蛋白表达鉴定[J].中国药理学通报,2010,(11):1516.
 ZHU Yong,WANG Chang dong,LIU Ge li,et al. Gene cloning and protein expression identification of duck MCHR2[J].Chinese Pharmacological Bulletin,2010,(01):1516.
 LIU Fang,GAO Nan nan,YANG Run mei,et al.Comparison of obesity models established in the different strains of mice and the mechanism of obese C57BL/6J mice[J].Chinese Pharmacological Bulletin,2013,(01):360.
 L Shuang yu,QIN Yao jun,YANG Yan jie,et al.Role of apelin in energy homeostasis[J].Chinese Pharmacological Bulletin,2013,(01):464.
 YE Gui fu,WANG Lu,YANG Rui yi,et al.Effects of hydrophobic fraction of Cajanus cajan (L.) Millspaugh on bone density and blood lipid level in obese and diabetic mice[J].Chinese Pharmacological Bulletin,2013,(01):961.
 CHEN Yi-ping,JIANG Xiao-hong,FENG Guang-yi,et al.Establishment and comparison of obese asthma models in different strains of mice[J].Chinese Pharmacological Bulletin,2016,(01):288.[doi:10.3969/j.issn.1001-1978.2016.02.027]


基金项目:湖南省研究生创新课题(No CX2012B078) 作者简介:杨永玉(1985-),男,博士,研究方向:肥胖与代谢性疾病,E-mail: yongyuyang@126.com; 胡长平(1969-),男,博士,教授,博士生导师,研究方向:心血管药理学、呼吸药理学,通讯作者,E-mail: huchangping@yahoo.com
更新日期/Last Update: 2016-01-15